SBFM Earnings

Quarterly EPS
$-188.00
Q3 2024
$-25.44
Q4 2024
$-88.00
Q1 2025
$-78.80
Q2 2025
$-38.00
Q3 2025
$-2.40
Q4 2025
$-50.00
Q1 2026
$-23.00
Q2 2026
Latest Revenue9.3M
Latest Net Income-1564048
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$23.009.3M-1564048-1.6%+70.8%
Q1 2026-$50.008.1M-1243869-9.1%+43.2%
Q4 2025-$2.408.6M-2140927-10.6%+90.6%
Q3 2025-$38.009.4M-883820+11.6%+79.8%
Q2 2025-$78.809.4M-1770834+1.2%+96.0%
Q1 2025-$88.008.9M-1179771+18.0%+78.0%
Q4 2024-$25.449.6M-2158212+24.9%+90.1%
Q3 2024-$188.008.4M-1197803+41.6%+98.1%
Q2 2024-$1,988.009.3M-494300——
Q1 2024-$400.007.5M-1283801——
Q4 2023-$257.527.7M-1250024——
Q3 2023-$10,144.006.0M-651482——
Sunshine Biopharma (SBFM) — Earnings